Contact Us marketing@medicilon.com
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
SERVICES
SERVICES
01 Drug Discovery
Chemistry Research Biology Research Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates Active Pharmaceutical Ingredients Pharmaceutical preparation Analytical Method Development and Quality Control CMC Filings Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics Drug Safety Evaluation DMPK Bioanalysis IND Filings
PLATFORM
PLATFORM
01 One-stop Integrated Services
Liposome Drug Development Drug Discovery Pharmaceutical Research Preclinical Research Botanical Drug Preclinical R&D
02 Innovative Drug R&D Services
Peptide Drug Conjugate (PDC) Antibody Nucleic Acid Drug Cellular Immunotherapies mRNA Vaccine PROTAC ADC
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection Metabolite Identification (MetID) Drug Forming Research Flow Cytometry Technology SEND Format Conversion Flow Sorting NanoString nCounter Detection Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
Rodent Cerebrovascular Disease Inflammatory and Immune Diseases IO Pharmacodynamic Model
05 High-end Preparations Technology Platform
Skin Topical Preparation Ophthalmic drug Inhalation drug
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service KRAS-targeted Drugs R&D Service GLP-1 New Drug R&D Service
07 Safety Assessment Lab of Process Chemistry

08 Public Services
CAREERS
Talent Development
Campus Recruitment
Recruitment
NEWS
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
INVESTORS
Stock Information
Investment Contact
CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
CN
×
中
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Nov 26,2021
FDA Launches Online Center for Biocompatibility Testing
Recently, the FDA launched the Medical Device Biocompatibility Evaluation Resource Center, an online system designed to help users better understand and complete the biocompatibility evaluation of medical devices. This system is not intended to replace the international standard ISO 10993-1 "Biological evaluation of medical devices-Part 1: Evaluation and testing within a risk management process,”, butRead more
More
FDA Launches Online Center for Biocompatibility Testing
Nov 26,2021
What is a Biocompatibility Test?
Biocompatibility refers to the mutual adaptability between medical materials and the patient's tissues and physiological systems. The clinical success of medical materials and their safe use are mainly due to their good biocompatibility. Generally, some medical materials will release toxic substances during use, resulting in incompatibility with patients. For the purpose of monitoring biocompatibility, medicalRead more
More
What is a Biocompatibility Test?
Nov 25,2021
Reagent Stability Testing of In Vitro Diagnosis
Stability research is an important content that runs through the entire IVD product development phase and supports the post-market research of IVD products. It is the basis for setting the product validity period. It can be used to judge the rationality of product production technology, formula selection, and packaging material selection. It is also AsRead more
More
Reagent Stability Testing of In Vitro Diagnosis
Nov 25,2021
The Failure of LC-MS Bioanalytical Research Method
A successful LC-MS bioanalysis method transfer can increase the confidence of the sender and recipient laboratories. However, because the transfer of LC-MS bioanalysis methods involves preliminary preparation, communication, and acceptance, and the content of each process is numerous, the negligence of individual details during the method transfer may cause the transfer to fail
More
The Failure of LC-MS Bioanalytical Research Method
Nov 24,2021
ELISA Protocol-Elisa Experiment Standard Operating Method
The Elisa experiment has been widely used clinically due to its high sensitivity and good specificity. However, each link in the operation has a greater impact on the detection effect of the experiment. If you are not careful, it may lead to incomplete color rendering and patterning. Wait for the result. ELISA Protocol The followingRead more
More
ELISA Protocol-Elisa Experiment Standard Operating Method
Nov 24,2021
Disadvantages of Indirect ELISA
Enzyme linked immunosorbent assay (ELISA) refers to the binding of antigen or antibody to the surface of a solid-phase carrier and maintain its immunological activity. The antigen or antibody is linked with a certain enzyme to form an enzyme-labeled antigen or antibody. This enzyme-labeled antigen or antibody retains its immune activity and enzyme activity.
More
Disadvantages of Indirect ELISA
Nov 23,2021
Happy Thanksgiving 2021
Dear Customer, At this happy holiday season of the year with warmth and love, we want to say thank you. We thank you, for knowing deep down that you care for the wellbeing of the human race and fight hard to find the cure, for letting us be a part of your journey and workRead more
More
Happy Thanksgiving 2021
Nov 22,2021
Hit to Lead and PCC
In innovative drug discovery based on targets, we have identified the targets, established a screening evaluation system, conducted high-throughput screening or other methods to obtain some active compounds, and these active compounds can be called: Hits. Usually In other words, the mainstream of high-throughput screening (HTS) is the use of economical and rapid chemical biologyRead more
More
Hit to Lead and PCC
Nov 19,2021
Discovery and Optimization of Lead Compounds
Discovery of Lead Compounds Hit to Lead The discovery of lead compounds is the process of turning the "hits” found in screening into "lead compounds” that can be further optimized. The lead compound may be a selected compound or a series of homologs, or it may be a compound derived from literature. However, for high-throughputRead more
More
Discovery and Optimization of Lead Compounds
Nov 19,2021
Injection vs. Oral Solid Preparations
From the perspective of various stages, there are big differences between domestic generic drug injections and oral solid preparations in terms of generic drug consistency evaluation, competition pattern, and overall market size. Domestic sales of injections account for too much From the PDB sample data, injections account for more than 60% of domestic prescription drugRead more
More
Injection vs. Oral Solid Preparations
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(781)535-1428(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->